Replies to post #603562 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

You're apparently not following the evolution of the regulations with regards to extending indications and getting coverage for other indications based on real world evidence, for drugs once they are approved for one indication.

You are apparently not following NWBO's 10Q where they said this:

In the future, we plan to conduct clinical trials of DCVax-L for other types of solid tumor cancers, beyond brain cancer, when resources permit.

But according to you, NWBO is lying and you know better than NWBO itself?
Perhaps you should send an email to NWBO that their 10Q contains a falsehood that there is no need for other DCVAXL clinical trials for other types of solid tumor cancers, beyond brain cancer, for surely the RA will provide NWBO approval for all solid tumors without the trails NWBO itself says it is panning.